Skip to content Skip to menu

Turnbull Government Ministry

Monday, 18 July 2016

Media Release

Medicines Australia would like to acknowledge the appointment of the Turnbull Government Ministry following the Federal Election.

With the recent confirmation that Prime Minister Turnbull will lead a majority government and today’s appointment of the Ministry, Medicines Australia looks forward to the resumption of Parliamentary business and policy development which is in the interests of the Australian people.

Medicines Australia welcomes the reappointment of the Hon. Sussan Ley MP as Minister for Health, Ageing and Sport. The reappointment of the Hon. Ken Wyatt MP as Assistant Health Minister and the elevation of Dr David Gillespie MP to the role of Assistant Minister for Rural Health are also welcomed by the innovative medicines industry.

We look forward to working together to implement the Government’s election policies to improve the clinical trials framework as well as faster approval processes for innovative medicines.

As the Prime Minister has acknowledged, the Government needs to do more in health within a challenging budget environment. It’s therefore of critical importance that reform focuses on inefficiencies and that precious health dollars are prioritised towards outcomes for patients which are proven to be not only clinically effective but cost effective too.

Medicines Australia also congratulates the Hon. Greg Hunt MP on his appointment as the Minister for Industry, Innovation & Science and Craig Laundy MP as his Assistant Minister. The National Innovation & Science Agenda (NISA) provides an important opportunity to build the biopharmaceutical sector in Australia by encouraging more collaboration and commercialisation between researchers and industry which will grow the economy and create jobs.

The reappointment of Ministers in other senior portfolios, including Treasury and Finance, Employment, Trade & Investment is a welcome decision which provides continuity and confidence for the innovative medicines sector which is an important industry for investment and employment in Australia.

Medicines Australia looks forward to continuing our engagement with the Turnbull Government on the development of policy which puts the interests of patients and the community first.

Contact:

James Boyce
Phone: 0423 239 265
Email:
James.Boyce@medicinesaustralia.com.au

Information

As COVID19 continues to spread, our thoughts go out to anyone who has been infected or impacted. We hope that you are taking the necessary precautions to keep safe and well, both at work and at home.

Medicines Australia continues to monitor the situation and take advice from the Department of Health and the World Health Organisation. We are focused on responding to the important short-term issues but are also ensuring we stay balanced and maintain a focus on the medium and long-term business for our industry along with the well-being of our people.

At Medicines Australia we have initiated the following to ensure we support containment measures to provide business continuity and the well-being of our staff.

  • All non-essential travel has been restricted or cancelled
  • All face-to-face meetings (with external stakeholders and members) have been changed to virtual meetings (where appropriate)
  • Staff have been provided with the latest official information on COVID-19 through a hot-link on the office intranet; this information is regularly monitored and updated
  • Flexible working arrangements are covered in our HR policy which will allow staff to work remotely, if or when required
  • Current IT infrastructure enables staff to work remotely and will be in use if any person needs to self-isolate
  • Visual reminders have been displayed around the office, providing information about best hygiene practices
  • Extra hand-sanitiser, tissues and cleaning products have been supplied to staff for their work spaces

Our latest information is located at medicinesaustralia.com.au/covid-19/

Top